Therapeutic PEG-ceramide nanomicelles synergize with salinomycin to target both liver cancer cells and cancer stem cells.
about
Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.Epidermal growth factor receptor aptamer-conjugated polymer-lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells.Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells.Recent advances in "smart" delivery systems for extended drug release in cancer therapy
P2860
Therapeutic PEG-ceramide nanomicelles synergize with salinomycin to target both liver cancer cells and cancer stem cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Therapeutic PEG-ceramide nanom ...... r cells and cancer stem cells.
@en
Therapeutic PEG-ceramide nanom ...... r cells and cancer stem cells.
@nl
type
label
Therapeutic PEG-ceramide nanom ...... r cells and cancer stem cells.
@en
Therapeutic PEG-ceramide nanom ...... r cells and cancer stem cells.
@nl
prefLabel
Therapeutic PEG-ceramide nanom ...... r cells and cancer stem cells.
@en
Therapeutic PEG-ceramide nanom ...... r cells and cancer stem cells.
@nl
P2093
P2860
P356
P1433
P1476
Therapeutic PEG-ceramide nanom ...... r cells and cancer stem cells.
@en
P2093
Beige Jiang
Fangyuan Xie
Guoqing Zhang
P2860
P304
P356
10.2217/NNM-2016-0408
P577
2017-04-25T00:00:00Z